INE485C01029
INE485C01029
IOL CHEMICALS & PHARMACEUTICAL
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 58.96B EUR | 42.7B EUR | 21.35B EUR | 24.18B EUR |
Enterprise Value | 58.31B EUR | 42.7B EUR | 22.05B EUR | 24.18B EUR |
Valuation Multiples | ||||
Trailing P/E | 34.27x | 25.4x | 15.51x | 28.62x |
Forward P/E | 19.31x | -- | -- | -- |
Price to Sales | 2.34x | 1.69x | 0.92x | 1.42x |
Price to Book | 3.28x | -- | 1.19x | -- |
EV/Revenue | 2.31x | 1.69x | 0.95x | 1.42x |
EV/EBITDA | 18.72x | 12.84x | 7.6x | 12.33x |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -- | -- | -- | -- |